帕克利塔塞尔抗癌疗法:从发现到临床使用
Haizheng Yu1, Fen Lan2, Yuan Zhuang1
1Department of Pharmaceutical Botany, School of Pharmacy, Naval Medical University, Shanghai 200433, China; Innovative Drug Research Center, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Chinese journal of natural medicines
|July 13, 2025
概括
帕克利塔塞尔 (PTX) 是一种强效的抗癌药物,它破坏了微管的动态,以杀死癌细胞. 本审查涵盖PTX的生产,交付和应用,以提高可访问性和有效性.
科学领域:
- 自然产品 化学 化学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕克利塔塞尔 (PTX) 是来自Taxus物种的重要天然产品,具有显著的抗癌活性.
- PTX通过与素相互作用而起作用,破坏微管体动力学,并诱导癌细胞死亡.
- 经批准的PTX衍生物具有低毒性,高效性和广泛的应用.
研究的目的:
- 审查Paclitaxel (PTX) 生产和交付方面的挑战和进展.
- 为PTX的合理开发和利用提供全面的参考.
- 探索PTX的来源,特性,机制,临床试验和化疗免疫疗法.
主要方法:
- 对帕克利塔克塞尔 (PTX) 研究的文献综述.
- 对PTX采购和生产方法的分析.
- 检查PTX的物理化学特性和抗癌机制.
主要成果:
- 对PTX的需求增加需要替代生产和增强的交付系统.
- 纳米载体应用在提高PTX生物可用性方面显示出前景.
- 目前正在进行的临床试验和化疗免疫治疗研究扩大了PTX的治疗潜力.
结论:
- 解决PTX可访问性挑战对于其广泛的临床使用至关重要.
- 在PTX生产和纳米输送方面的进步对于提高其治疗指数至关重要.
- 对PTX机制和应用的持续研究将优化其在癌症治疗中的作用.
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


